Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00709878 · ClinicalTrials.gov registry record
Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors
A clinical trial of Skin Rash, sponsored by Northwestern University.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT00709878 is a study of Skin Rash that has completed, run by Northwestern University. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00709878, a study of Skin Rash, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the microscopic findings of skin rash associated with the use of chemotherapeutic anticancer agents known as epidermal growth factor inhibitors (EGFRIs).
Conditions Studied
Interventions
- PROCEDURE Skin Biopsy of Skin Rash Secondary to EGFRI Use
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00709878
The ClinicalTrials.gov registry entry for NCT00709878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Rash appearing as the primary indexed condition, and to 1 intervention - of which Skin Biopsy of Skin Rash Secondary to EGFRI Use is the first listed.
NCT00709878 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00709878 about?
NCT00709878 is a clinical study titled "Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors". The purpose of this study is to characterize the microscopic findings of skin rash associated with the use of chemotherapeutic anticancer agents known as epidermal growth factor inhibitors (EGFRIs).
What is the current status of trial NCT00709878?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-04. Estimated completion is 2010-08.
What conditions does trial NCT00709878 study?
This clinical trial studies the following conditions: Skin Rash.
What interventions are being tested in trial NCT00709878?
The interventions under investigation include: Skin Biopsy of Skin Rash Secondary to EGFRI Use (PROCEDURE).
Who is sponsoring clinical trial NCT00709878?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00709878 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.